3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
16
Fallopian Tube Neoplasms
14
Sarcoma
5
Breast Neoplasms
5
Carcinoma, Ovarian Epithelial
4
Neoplasms
3
Neoplasm Metastasis
3
Triple Negative Breast Neoplasms
2
Sarcoma, Ewing
2
Multi-centric Castleman's Disease
2
Hodgkin Disease
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Vaccinia
1
Uterine Cervical Neoplasms
1
Sarcoma, Synovial
1
Sarcoma, Kaposi
1
Rhabdomyosarcoma
1
Recurrent Platinum-Sensitive Fallopian Tube Endometrioid Adenocarcinoma
1
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
1
Recurrence
1
Peritoneal Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Ovarian Cancer Recurrent
1
Osteosarcoma
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Non-Hodgkin
1
Lymphadenopathy
1
Interventions
selinexor
2
pembrolizumab
2
pazopanib
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ifosfamide
2
Doxorubicin
2
tazemetostat
1
metarrestin
1
fludarabine phosphate
1
fludarabine
1
Specimen Handling
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Mesna
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
liposomal doxorubicin
×
90 days
×
Clear all
No trials found.